North America Neurorehabilitation Devices Market Forecast to 2031 - Regional Analysis - by Product Type (Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, and Wearable Devices), Application (Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson's Disease, Cerebral Palsy, and Others), and End User (Rehabilitation Centers, Hospitals and Clinics, and Home Care)
The North America neurorehabilitation devices market was valued at US$ 1,512.12 million in 2023 and is expected to reach US$ 3,891.70 million by 2031; it is estimated to register a CAGR of 12.5% from 2023 to 2031.
Increasing Prevalence of Neurological Diseases Fuels North America Neurorehabilitation Devices Market
Patients suffering from neurological diseases such as stroke, Parkinson’s disease, multiple sclerosis (MS), Alzheimer's disease, and cerebral palsy require neurorehabilitation devices to improve their motor skills, cognitive abilities, and overall quality of life.
Stroke is a leading cause of long-term disability and reduces mobility in half of stroke survivors aged 65 and older. As per the Global Stroke Fact Sheet 2022, every year, there are more than 12.2 million new strokes. One in four people over 25 are likely to have a stroke in their lifetime. The factsheet also stated that there are more than 101 million people currently living across the globe who have already experienced a stroke. The Centers for Disease Control and Prevention estimated that annually, more than 795,000 people in the US have a stroke.
Neurorehabilitation devices are widely used to improve memory and communication difficulties and reduce neuropsychiatric symptoms, thereby helping improve the quality of life of dementia patients. Per the World Health Organization fact sheet in 2023, globally, more than 55 million people have dementia, and approximately 10 million new cases are diagnosed every year.
As per the Parkinson's Foundation, in 2022, approximately one million people in the US had Parkinson's disease, and ~90,000 new cases are diagnosed every year. The number of patients who have Parkinson's disease is expected to rise to 1.2 million by 2030.
The increasing prevalence of neurological diseases worldwide creates a burden on healthcare systems, bolstering the demand for neurorehabilitation devices.
North America Neurorehabilitation Devices Market Overview
The North America neurorehabilitation devices Market is segmented into the US, Canada, and Mexico. The US is one of the most developed countries in North America. The country accounts for the major market share owing to the surging prevalence of neurological disorders, followed by the surging technological advancement in the field of neurorehabilitation devices. A large portion of the US population suffers from neurological conditions such as multiple sclerosis, cerebral palsy, etc. According to the Birth Injury Justice Center, cerebral palsy is the most common physical childhood disability affecting 1 million people in the US. Moreover, an increasing number of neuro rehab centers equipped with advanced technology is also expected to support the market growth during the forecast period. For instance, in June 2024, Neurofenix launched a virtual clinic for home-based Neuro Rehab in Florida to help patients perform varied exercises aimed at improving motor skills and functional ability, all from the comfort of their homes. In addition, in October 2020, Neuro Rehab VR its XR Therapy System, a clinically validated and FDA-registered virtual reality (VR) therapy system for neurological rehabilitation and physical therapy treatment and assessment in clinical environments. Therefore, above mentioned factors are expected to boost the neurorehabilitation market growth in the coming years.
North America Neurorehabilitation Devices Market Revenue and Forecast to 2031 (US$ Million)
North America Neurorehabilitation Devices Market Segmentation
The North America neurorehabilitation devices market is categorized into product type, application, end user, and country.
By product type, the North America neurorehabilitation devices market is segmented into neurorobotic system, brain computer interface, non-invasive stimulators, and wearable devices. The brain computer interface segment held the largest share of the North America neurorehabilitation devices market share in 2023.
In terms of application, the North America neurorehabilitation devices market is segmented into stroke, traumatic brain injury, spinal cord injury, Parkinson's disease, cerebral palsy, and others. The stroke segment held the largest share of the North America neurorehabilitation devices market share in 2023.
By end user, the North America neurorehabilitation devices market is segmented into rehabilitation centers, hospitals & clinics, and home care. The hospitals & clinics segment held the largest share of the North America neurorehabilitation devices market share in 2023.
Based on country, the North America neurorehabilitation devices market is segmented into the US, Canada, and Mexico. The US segment held the largest share of North America neurorehabilitation devices Market in 2023.
Abbott Laboratories, BIONIK, BioXtreme Ltd, Blackrock Microsystems Inc, Ekso Bionics Holdings Inc, EMOTIV, Hocoma AG, Medtronic Plc, Renishaw Plc, and Tyromotion GmbH are some of the leading companies operating in the North America neurorehabilitation devices market.
Reason to buy
Increasing Prevalence of Neurological Diseases Fuels North America Neurorehabilitation Devices Market
Patients suffering from neurological diseases such as stroke, Parkinson’s disease, multiple sclerosis (MS), Alzheimer's disease, and cerebral palsy require neurorehabilitation devices to improve their motor skills, cognitive abilities, and overall quality of life.
Stroke is a leading cause of long-term disability and reduces mobility in half of stroke survivors aged 65 and older. As per the Global Stroke Fact Sheet 2022, every year, there are more than 12.2 million new strokes. One in four people over 25 are likely to have a stroke in their lifetime. The factsheet also stated that there are more than 101 million people currently living across the globe who have already experienced a stroke. The Centers for Disease Control and Prevention estimated that annually, more than 795,000 people in the US have a stroke.
Neurorehabilitation devices are widely used to improve memory and communication difficulties and reduce neuropsychiatric symptoms, thereby helping improve the quality of life of dementia patients. Per the World Health Organization fact sheet in 2023, globally, more than 55 million people have dementia, and approximately 10 million new cases are diagnosed every year.
As per the Parkinson's Foundation, in 2022, approximately one million people in the US had Parkinson's disease, and ~90,000 new cases are diagnosed every year. The number of patients who have Parkinson's disease is expected to rise to 1.2 million by 2030.
The increasing prevalence of neurological diseases worldwide creates a burden on healthcare systems, bolstering the demand for neurorehabilitation devices.
North America Neurorehabilitation Devices Market Overview
The North America neurorehabilitation devices Market is segmented into the US, Canada, and Mexico. The US is one of the most developed countries in North America. The country accounts for the major market share owing to the surging prevalence of neurological disorders, followed by the surging technological advancement in the field of neurorehabilitation devices. A large portion of the US population suffers from neurological conditions such as multiple sclerosis, cerebral palsy, etc. According to the Birth Injury Justice Center, cerebral palsy is the most common physical childhood disability affecting 1 million people in the US. Moreover, an increasing number of neuro rehab centers equipped with advanced technology is also expected to support the market growth during the forecast period. For instance, in June 2024, Neurofenix launched a virtual clinic for home-based Neuro Rehab in Florida to help patients perform varied exercises aimed at improving motor skills and functional ability, all from the comfort of their homes. In addition, in October 2020, Neuro Rehab VR its XR Therapy System, a clinically validated and FDA-registered virtual reality (VR) therapy system for neurological rehabilitation and physical therapy treatment and assessment in clinical environments. Therefore, above mentioned factors are expected to boost the neurorehabilitation market growth in the coming years.
North America Neurorehabilitation Devices Market Revenue and Forecast to 2031 (US$ Million)
North America Neurorehabilitation Devices Market Segmentation
The North America neurorehabilitation devices market is categorized into product type, application, end user, and country.
By product type, the North America neurorehabilitation devices market is segmented into neurorobotic system, brain computer interface, non-invasive stimulators, and wearable devices. The brain computer interface segment held the largest share of the North America neurorehabilitation devices market share in 2023.
In terms of application, the North America neurorehabilitation devices market is segmented into stroke, traumatic brain injury, spinal cord injury, Parkinson's disease, cerebral palsy, and others. The stroke segment held the largest share of the North America neurorehabilitation devices market share in 2023.
By end user, the North America neurorehabilitation devices market is segmented into rehabilitation centers, hospitals & clinics, and home care. The hospitals & clinics segment held the largest share of the North America neurorehabilitation devices market share in 2023.
Based on country, the North America neurorehabilitation devices market is segmented into the US, Canada, and Mexico. The US segment held the largest share of North America neurorehabilitation devices Market in 2023.
Abbott Laboratories, BIONIK, BioXtreme Ltd, Blackrock Microsystems Inc, Ekso Bionics Holdings Inc, EMOTIV, Hocoma AG, Medtronic Plc, Renishaw Plc, and Tyromotion GmbH are some of the leading companies operating in the North America neurorehabilitation devices market.
Reason to buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America neurorehabilitation devices market.
- Highlights key business priorities to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America neurorehabilitation devices market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America neurorehabilitation devices market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
- Abbott Laboratories
- BIONIK
- BioXtreme Ltd
- Blackrock Microsystems Inc
- Ekso Bionics Holdings Inc
- EMOTIV
- Hocoma AG
- Medtronic Plc
- Renishaw Plc
- Tyromotion GmbH
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Average Selling Price
5. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET - KEY MARKET DYNAMICS
5.1 North America Neurorehabilitation Devices Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Neurological Diseases
5.2.2 Growing Number of Clinical Studies on Neurorehabilitation Devices
5.3 Market Restraints
5.3.1 High Costs Associated with Neurorehabilitation Devices
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Technological Advancements
5.6 Impact of Drivers and Restraints:
6. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET - ANALYSIS
6.1 North America Neurorehabilitation Devices Market Revenue (US$ Million), 2021-2031
6.2 North America Neurorehabilitation Devices Market Forecast Analysis
7. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET ANALYSIS - BY PRODUCT TYPE
7.1 Neurorobotic System
7.1.1 Overview
7.1.2 Neurorobotic System: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Brain Computer Interface
7.2.1 Overview
7.2.2 Brain Computer Interface: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Non-invasive Stimulators
7.3.1 Overview
7.3.2 Non-invasive Stimulators: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Wearable Devices
7.4.1 Overview
7.4.2 Wearable Devices: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET ANALYSIS - BY APPLICATION
8.1 Stroke
8.1.1 Overview
8.1.2 Stroke: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Traumatic Brain Injury
8.2.1 Overview
8.2.2 Traumatic Brain Injury: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Spinal Cord Injury
8.3.1 Overview
8.3.2 Spinal Cord Injury: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Parkinson's Disease
8.4.1 Overview
8.4.2 Parkinson's Disease: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Cerebral Palsy
8.5.1 Overview
8.5.2 Cerebral Palsy: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET ANALYSIS - BY END USER
9.1 Rehabilitation Centers
9.1.1 Overview
9.1.2 Rehabilitation Centers: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Home Care
9.3.1 Overview
9.3.2 Home Care: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
10. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET - COUNTRY ANALYSIS
10.1 North America
10.1.1 North America Neurorehabilitation Devices Market - Revenue and Forecast Analysis - by Country
10.1.1.1 North America Neurorehabilitation Devices Market - Revenue and Forecast Analysis - by Country
10.1.1.2 United States: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.1.2.1 United States: North America Neurorehabilitation Devices Market Share - by Product Type
10.1.1.2.2 United States: North America Neurorehabilitation Devices Market Share - by Application
10.1.1.2.3 United States: North America Neurorehabilitation Devices Market Share - by End User
10.1.1.3 Canada: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.1.3.1 Canada: North America Neurorehabilitation Devices Market Share - by Product Type
10.1.1.3.2 Canada: North America Neurorehabilitation Devices Market Share - by Application
10.1.1.3.3 Canada: North America Neurorehabilitation Devices Market Share - by End User
10.1.1.4 Mexico: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.1.4.1 Mexico: North America Neurorehabilitation Devices Market Share - by Product Type
10.1.1.4.2 Mexico: North America Neurorehabilitation Devices Market Share - by Application
10.1.1.4.3 Mexico: North America Neurorehabilitation Devices Market Share - by End User
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
12. COMPANY PROFILES
12.1 Blackrock Microsystems Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Hocoma AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Medtronic Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Tyromotion GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ekso Bionics Holdings Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BIONIK
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Abbott Laboratories
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Renishaw Plc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 EMOTIV
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 BioXtreme Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Average Selling Price
5. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET - KEY MARKET DYNAMICS
5.1 North America Neurorehabilitation Devices Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Neurological Diseases
5.2.2 Growing Number of Clinical Studies on Neurorehabilitation Devices
5.3 Market Restraints
5.3.1 High Costs Associated with Neurorehabilitation Devices
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Technological Advancements
5.6 Impact of Drivers and Restraints:
6. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET - ANALYSIS
6.1 North America Neurorehabilitation Devices Market Revenue (US$ Million), 2021-2031
6.2 North America Neurorehabilitation Devices Market Forecast Analysis
7. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET ANALYSIS - BY PRODUCT TYPE
7.1 Neurorobotic System
7.1.1 Overview
7.1.2 Neurorobotic System: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Brain Computer Interface
7.2.1 Overview
7.2.2 Brain Computer Interface: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Non-invasive Stimulators
7.3.1 Overview
7.3.2 Non-invasive Stimulators: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Wearable Devices
7.4.1 Overview
7.4.2 Wearable Devices: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET ANALYSIS - BY APPLICATION
8.1 Stroke
8.1.1 Overview
8.1.2 Stroke: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Traumatic Brain Injury
8.2.1 Overview
8.2.2 Traumatic Brain Injury: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Spinal Cord Injury
8.3.1 Overview
8.3.2 Spinal Cord Injury: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Parkinson's Disease
8.4.1 Overview
8.4.2 Parkinson's Disease: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Cerebral Palsy
8.5.1 Overview
8.5.2 Cerebral Palsy: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET ANALYSIS - BY END USER
9.1 Rehabilitation Centers
9.1.1 Overview
9.1.2 Rehabilitation Centers: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Home Care
9.3.1 Overview
9.3.2 Home Care: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
10. NORTH AMERICA NEUROREHABILITATION DEVICES MARKET - COUNTRY ANALYSIS
10.1 North America
10.1.1 North America Neurorehabilitation Devices Market - Revenue and Forecast Analysis - by Country
10.1.1.1 North America Neurorehabilitation Devices Market - Revenue and Forecast Analysis - by Country
10.1.1.2 United States: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.1.2.1 United States: North America Neurorehabilitation Devices Market Share - by Product Type
10.1.1.2.2 United States: North America Neurorehabilitation Devices Market Share - by Application
10.1.1.2.3 United States: North America Neurorehabilitation Devices Market Share - by End User
10.1.1.3 Canada: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.1.3.1 Canada: North America Neurorehabilitation Devices Market Share - by Product Type
10.1.1.3.2 Canada: North America Neurorehabilitation Devices Market Share - by Application
10.1.1.3.3 Canada: North America Neurorehabilitation Devices Market Share - by End User
10.1.1.4 Mexico: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.1.4.1 Mexico: North America Neurorehabilitation Devices Market Share - by Product Type
10.1.1.4.2 Mexico: North America Neurorehabilitation Devices Market Share - by Application
10.1.1.4.3 Mexico: North America Neurorehabilitation Devices Market Share - by End User
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
12. COMPANY PROFILES
12.1 Blackrock Microsystems Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Hocoma AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Medtronic Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Tyromotion GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ekso Bionics Holdings Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BIONIK
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Abbott Laboratories
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Renishaw Plc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 EMOTIV
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 BioXtreme Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Neurorehabilitation Devices Market Segmentation
Table 2. North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Table 3. North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product Type
Table 4. North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
Table 5. North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
Table 6. North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
Table 7. United States: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
Table 8. United States: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
Table 9. United States: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 10. Canada: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
Table 11. Canada: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
Table 12. Canada: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 13. Mexico: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
Table 14. Mexico: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
Table 15. Mexico: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 16. Glossary of Terms, Neurorehabilitation Devices Market
Table 1. North America Neurorehabilitation Devices Market Segmentation
Table 2. North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Table 3. North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product Type
Table 4. North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
Table 5. North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
Table 6. North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
Table 7. United States: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
Table 8. United States: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
Table 9. United States: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 10. Canada: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
Table 11. Canada: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
Table 12. Canada: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 13. Mexico: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Product Type
Table 14. Mexico: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Application
Table 15. Mexico: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by End User
Table 16. Glossary of Terms, Neurorehabilitation Devices Market
LIST OF FIGURES
Figure 1. North America Neurorehabilitation Devices Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Average Selling Price, North America (US$/ Unit)
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Neurorehabilitation Devices Market Revenue (US$ Million), 2021-2031
Figure 6. North America Neurorehabilitation Devices Market Share (%) - by Product Type (2023 and 2031)
Figure 7. Neurorobotic System: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 8. Brain Computer Interface: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 9. Non-invasive Stimulators: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 10. Wearable Devices: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 11. North America Neurorehabilitation Devices Market Share (%) - by Application (2023 and 2031)
Figure 12. Stroke: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 13. Traumatic Brain Injury: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 14. Spinal Cord Injury: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 15. Parkinson's Disease: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 16. Cerebral Palsy: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 17. Others: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 18. North America Neurorehabilitation Devices Market Share (%) - by End User (2023 and 2031)
Figure 19. Rehabilitation Centers: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 20. Hospitals and Clinics: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 21. Home Care: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 22. North America Neurorehabilitation Devices Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 23. United States: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 24. Canada: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 25. Mexico: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 1. North America Neurorehabilitation Devices Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Average Selling Price, North America (US$/ Unit)
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Neurorehabilitation Devices Market Revenue (US$ Million), 2021-2031
Figure 6. North America Neurorehabilitation Devices Market Share (%) - by Product Type (2023 and 2031)
Figure 7. Neurorobotic System: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 8. Brain Computer Interface: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 9. Non-invasive Stimulators: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 10. Wearable Devices: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 11. North America Neurorehabilitation Devices Market Share (%) - by Application (2023 and 2031)
Figure 12. Stroke: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 13. Traumatic Brain Injury: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 14. Spinal Cord Injury: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 15. Parkinson's Disease: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 16. Cerebral Palsy: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 17. Others: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 18. North America Neurorehabilitation Devices Market Share (%) - by End User (2023 and 2031)
Figure 19. Rehabilitation Centers: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 20. Hospitals and Clinics: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 21. Home Care: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 22. North America Neurorehabilitation Devices Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 23. United States: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 24. Canada: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 25. Mexico: North America Neurorehabilitation Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
